tiprankstipranks
Calidi Biotherapeutics (CLDI)
NYSE MKT:CLDI
US Market

Calidi Biotherapeutics (CLDI) Financial Statements

101 Followers

Calidi Biotherapeutics Financial Overview

Calidi Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-10.084; its P/E ratio is -0.17; Calidi Biotherapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-2.75. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -8.01M$ -1.71M$ -4.19M$ -2.16M$ -2.71M
EBITDA$ -7.65M$ -142.87K$ -4.17M$ -2.14M$ -2.71M
Net Income Common Stockholders$ -8.23M$ -2.02M$ -4.27M$ -2.22M$ -2.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.95M$ 10.15M$ 669.87K$ 82.83K$ 93.89K
Total Assets$ 10.02M$ 18.59M$ 44.01M$ 43.18M$ 42.85M
Total Debt$ 6.43M$ 7.41M$ 1.49M$ 1.46M$ 1.22M
Net Debt$ 4.48M$ -2.74M$ 820.13K$ 1.38M$ 1.13M
Total Liabilities$ 18.25M$ 19.68M$ 12.77M$ 8.15M$ 5.61M
Stockholders Equity$ -8.23M$ -1.09M$ -11.97M$ -7.88M$ 37.25M
Cash Flow-
Free Cash Flow$ -5.26M$ -22.89M$ 381.50K$ 192.29K$ 1.17M
Operating Cash Flow$ -5.19M$ -22.37M$ 381.50K$ 192.29K$ 1.17M
Investing Cash Flow$ -35.00K$ 277.31K$ -294.46K$ -425.85K$ -1.91M
Financing Cash Flow$ -2.96M$ 31.28M$ 500.00K$ 222.50K$ 797.50K
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

Calidi Biotherapeutics Debt to Assets

Calidi Biotherapeutics Cash Flow

Calidi Biotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis